Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Abbott Laboratories."
12 result(s) displayed (1 - 12 of 19)
Abbott's VP of licensing and acquisitions discuss the pharmaceutical giant's acquisition strategy as it prepares to split into two different companies at the start of 2013. Continue reading
Posted on November 19, 2012 1:04 PM
The 26-year-old company will combine with the privately held developer of hepatitis C compounds in an effort to get in on a nascent HCV market that is rapidly drawing a crowd. Continue reading
Posted on October 19, 2012 3:50 PM
Jefferies & Co.'s Jeffrey Holford identifies a few potential targets for the Swiss pharma giant, but while other analysts agree an earnings slide is coming, they don't share his M&A yearning. Continue reading
Posted on September 27, 2012 4:01 PM
The healthcare conglomerate acquires a kidney disease compound from Action Pharma for $110 million. Continue reading
Posted on May 3, 2012 3:48 PM
Winners of this year's MACD awards (don't worry, we explain what this is and why it's important) are J.P. Morgan Chase, Abbott Laboratories, Exxon Mobil, Oracle and Walt Disney Continue reading
Posted on September 20, 2011 4:30 PM
The new issue of The Deal magazine features 2011's Most Admired Corporate Dealmakers Continue reading
Posted on September 19, 2011 1:20 PM
The Deal magazine's Suzanne Miller explains why our audience chose Abbott Laboratories, Disney, J.P. Morgan, Exxon Mobil and Oracle as the 2011 Most Admired Corporate Dealmakers. Continue reading
Posted on September 19, 2011 7:39 AM
This year's Most Admired Corporate Dealmakers stand out as much for their discipline as for their dealmaking zeal. Continue reading
Posted on September 18, 2011 8:00 PM
After some savvy acquisitions, it's now the second-largest pharma in the world's fastest-growing markets. Continue reading
Posted on September 18, 2011 8:00 PM
Five companies, including biotech, medtech and pharma, raise nearly $230 million. Continue reading
Posted on September 15, 2011 11:23 AM
French drugmaker Sanofi-Aventis SA has become the latest Big Pharma entity to strike in India, using subsidiary Aventis Pharma Ltd. to grab a division of Mumbai's Universal Medicare Private Ltd.Aventis Pharma, an India-based entity in which Sanofi owns a 60.4%... Continue reading
Posted on August 24, 2011 2:46 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
